Early Phase 1 HD Clinical Trials
5 recruitingEarly Phase 1
What is a Early Phase 1 trial?
Early Phase 1 trials are the earliest stage of testing in humans. These small studies focus on how a drug is processed in the body and how it affects the body, often enrolling just a handful of participants to establish initial safety data.
Showing 1–5 of 5 trials
Recruiting
Early Phase 1
A Clinical Study Evaluating the Safety and Efficacy of GT729 Universal Cell Injection in the Treatment of Refractory or Relapsed Chronic Graft-versus-host Disease (cGVHD)
cGVHD
Grit Biotechnology36 enrolled1 locationNCT07253259
Recruiting
Early Phase 1
iMagemHTT-009- FIH Evaluation of Novel Mutant Huntingtin PET Radioligand [11C]CHDI-00491009
Huntington’s DiseaseHuntington DiseasePositron Emission Tomography+6 more
CHDI Foundation, Inc.27 enrolled1 locationNCT06634628
Recruiting
Early Phase 1
Treatment of Refractory cGVHD by Donor-derived Treg Cell Injection Combined With Recombinant Human Interleukin-2
cGVHD
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine18 enrolled1 locationNCT06920199
Recruiting
Early Phase 1
Evaluation of the Electronic Cigarette Withdrawal Syndrome
E-cigarette useWithdrawal
Johns Hopkins University150 enrolled1 locationNCT06066996
Recruiting
Early Phase 1
A study to determine the safety, tolerability and effects of orally administered 3,5-diiodothyropropionic acid (DITPA) in patients with Allan-Herndon-Dudley-Syndrome (AHDS).
Allan-Herndon-Dudley Syndrome (AHDS)
Zarion Pharmaceuticals10 enrolled1 locationACTRN12611000472976